Concepedia

Toshinobu Yamamoto

TY

19

Publications

1.2K

Citations

17

H-Index

1998

Active since

Affiliations

Sapporo Medical University(Current)

Mitsubishi Tanabe Pharma Corporation

Gifu University

Osaka University Hospital

University of Shizuoka

Toshinobu Yamamoto is an author at Sapporo Medical University specializing in medicine, cell signaling, and signal transduction.

Top concepts

Publications per year

1998–2020

19

Publications

19

Identification of Toxin A-Negative, Toxin B-Positive <i>Clostridium difficile</i> by PCR

Haru Kato, Naoki Kato, Kunitomo Watanabe et al. · Journal of Clinical Microbiology · 1998 · 361 citations · Full text

, , +17

Amiselimod, a novel sphingosine 1‐phosphate receptor‐1 modulator, has potent therapeutic efficacy for autoimmune diseases, with low bradycardia risk

Kunio Sugahara, Yasuhiro Maeda, Kyoko Shimano et al. · British Journal of Pharmacology · 2016 · 83 citations · Full text

Transforming growth factor‐β induces epithelial to mesenchymal transition by down‐regulation of claudin‐1 expression and the fence function in adult rat hepatocytes

Takashi Kojima, Kenichi Takano, Toshinobu Yamamoto et al. · Liver International · 2007 · 81 citations

Analysis of <i>Clostridium difficile</i> Isolates from Nosocomial Outbreaks at Three Hospitals in Diverse Areas of Japan

Haru Kato, Naoki Kato, Kunitomo Watanabe et al. · Journal of Clinical Microbiology · 2001 · 75 citations · Full text

IL-1β regulates expression of Cx32, occludin, and claudin-2 of rat hepatocytes via distinct signal transduction pathways

Toshinobu Yamamoto, Takashi Kojima, Masaki Murata et al. · Experimental Cell Research · 2004 · 70 citations

, , +12

Rows per page

1–5 of 19